Clinical trials
Phase 1 Aneurysm trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 5 |
| Recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Missouri-Columbia | 6 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Colorado State University | 2 |
| University of Wisconsin, Madison | 2 |
| Arizona Heart Institute | 1 |
| Bolton Medical | 1 |
| Edge Therapeutics Inc | 1 |
| Konstantin V. Slavin | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| State University of New York - Upstate Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aneurysm | 24 |
| Obesity | 6 |
| Hypertension | 3 |
| Aortic Aneurysm, Abdominal | 2 |
| Hypercholesterolemia | 2 |
| Hypoxia | 2 |
| Insulin Resistance | 2 |
| Subarachnoid Hemorrhage | 2 |
| Anemia, Sickle Cell | 1 |
| Aortic Aneurysm | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.